Man Group’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,264
Closed -$173K 2203
2025
Q2
$173K Sell
13,264
-3,231
-20% -$38.2K ﹤0.01% 2090
2025
Q1
$175K Sell
16,495
-5,473
-25% -$86.9K ﹤0.01% 2050
2024
Q4
$373K Sell
21,968
-4,168
-16% -$78.5K ﹤0.01% 1735
2024
Q3
$607K Buy
26,136
+9,346
+56% +$200K ﹤0.01% 1619
2024
Q2
$409K Sell
16,790
-45,799
-73% -$1.39M ﹤0.01% 1730
2024
Q1
$2.11M Sell
62,589
-23,914
-28% -$847K 0.01% 1295
2023
Q4
$2.73M Buy
+86,503
New +$2.06M 0.01% 1175
2023
Q3
Hold
0
1267
2022
Q1
Sell
-17,390
Closed -$644K 2175
2021
Q4
$644K Sell
17,390
-2,569
-13% -$105K ﹤0.01% 1464
2021
Q3
$954K Buy
19,959
+2,694
+16% +$121K ﹤0.01% 1349
2021
Q2
$584K Sell
17,265
-1,811
-9% -$61.3K ﹤0.01% 1516
2021
Q1
$788K Buy
19,076
+7,338
+63% +$437K ﹤0.01% 1353
2020
Q4
$509K Sell
11,738
-186
-2% -$12.6K ﹤0.01% 1548
2020
Q3
$512K Buy
+11,924
New +$592K ﹤0.01% 1544

Other funds holding ARCT